These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3743639)

  • 1. The effect of propranolol on blood pressure and central MOPEG concentration in the conscious spontaneously hypertensive rat.
    Keeton TK; Hall JS
    Eur J Pharmacol; 1986 Jun; 125(2):293-6. PubMed ID: 3743639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased norepinephrine release in anterior hypothalamus of NaCl-sensitive spontaneously hypertensive rats during high NaCl intake.
    Chen CW; Chen YF; Meng QC; Wyss JM; Oparil S
    Brain Res; 1991 Nov; 565(1):135-41. PubMed ID: 1723021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine content changes in brain regions of spontaneously hypertensive rats under immobilization stress.
    Nomura M; Okamura K
    J Neurochem; 1989 Mar; 52(3):933-7. PubMed ID: 2918315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4.
    Calderini G; Morselli PL; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):345-50. PubMed ID: 1234553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measurement of central noradrenergic activity in spontaneously hypertensive rats: a comparison of free 3,4-dihydroxyphenylethyleneglycol levels with FLA-63 induced noradrenaline depletion.
    Howes LG; Summers RJ; Rowe PR; Louis WJ
    J Hypertens; 1985 Jun; 3(3):237-42. PubMed ID: 4020130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An opposing role for the adrenals in the hypotensive effects of propranolol in the spontaneously hypertensive rat.
    Nijkamp FP; Van Den Bosch R; De Jong W
    Eur J Pharmacol; 1979 Jun; 56(3):187-95. PubMed ID: 477716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short and long-term effects of reserpine on the concentration of 1-(4-hydroxy-3-methoxyphenyl)-ethane-1,2-diol (MOPEG-SO4) in the brain of the rat.
    Bareggi SR; Genovese E; Markey K
    Br J Pharmacol; 1979 Apr; 65(4):573-8. PubMed ID: 435682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol and atenolol inhibit norepinephrine spillover rate into plasma in conscious spontaneously hypertensive rats.
    Keeton TK; Biediger AM
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):47-55. PubMed ID: 1685557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of trauma on the activity of central noradrenergic neurones.
    Stoner HB; Hunt A
    Brain Res; 1976 Aug; 112(2):337-46. PubMed ID: 953712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG).
    Keeton TK; Krutzsch H; Lovenberg W
    Science; 1981 Feb; 211(4482):586-8. PubMed ID: 7455697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic beta-blocker treatment on catecholamine levels in spontaneously hypertensive rats.
    Heimburger M; Denoroy L; Renaud B; Sassard J; Cohen Y; Wepierre J
    Biochem Pharmacol; 1983 Sep; 32(18):2739-43. PubMed ID: 6138041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single and multiple doses of desipramine (DMI) on endogenous levels of 3-methoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain.
    Bareggi SR; Markey K; Genovese E
    Eur J Pharmacol; 1978 Aug; 50(4):301-6. PubMed ID: 699958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physiological role and clinical significance of 3-methoxy-4-hydroxyethyleneglycol, a noradrenaline metabolite (review of the literature)].
    Bol'shakova TD; Shenderovich MIa
    Vopr Med Khim; 1987; 33(6):3-11. PubMed ID: 3328414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the metabolism of catecholamines in the central nervous system of the mouse.
    Ceasar PM; Hague P; Sharman DF; Werdinius B
    Br J Pharmacol; 1974 Jun; 51(2):187-95. PubMed ID: 4141637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of several narcotic analgesics on brain levels of 3-methoxy-4-hydroxyphenylethylene glycol sulfate in the rat.
    LoPachin RM; Reigle TG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):151-8. PubMed ID: 29961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of renal sympathetic nerve activity by metoprolol or propranolol in conscious spontaneously hypertensive rats.
    Majcherczyk S; Mikulski A; Sjölander M; Thorén P
    Br J Pharmacol; 1987 Aug; 91(4):711-4. PubMed ID: 3664074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the antihypertensive effect of propranolol caused by an action within the central nervous system?
    Smits JF; van Essen H; Struyker-Boudier HA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):221-5. PubMed ID: 7452486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pergolide on MOPEG sulphate levels in rat brain regions.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1983 Jan; 35(1):57-8. PubMed ID: 6131970
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic propranolol treatment decreases cardiac beta-adrenoceptors in spontaneously hypertensive rats.
    Baker SP; Katovich MJ
    Eur J Pharmacol; 1982 Mar; 78(4):479-82. PubMed ID: 6281038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.